DIA
BIIB icon

Denver Investment Advisors’s Biogen BIIB Stock Holding History

Denver Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-789
Closed -$242K – 472
2015
Q4 		$242K Sell
789
-200
-20% -$57.5K 0.01% 420
2015
Q3 		$289K Sell
989
-1,250
-56% -$413K 0.01% 405
2015
Q2 		$904K Buy
2,239
+1,214
+118% +$487K 0.03% 300
2015
Q1 		$433K Sell
1,025
-10
-1% -$3.94K 0.01% 424
2014
Q4 		$351K Sell
1,035
-13,796
-93% -$4.46M 0.01% 435
2014
Q3 		$4.91M Buy
14,831
+45
+0.3% +$14.8K 0.16% 152
2014
Q2 		$4.66M Sell
14,786
-369
-2% -$111K 0.14% 169
2014
Q1 		$4.64M Sell
15,155
-4,532
-23% -$1.44M 0.14% 197
2013
Q4 		$5.5M Buy
19,687
+1,963
+11% +$508K 0.16% 183
2013
Q3 		$4.29M Sell
17,724
-457
-3% -$102K 0.09% 244
2013
Q2 		$3.93M Buy
+18,181
New +$3.88M 0.09% 238

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Denver Investment Advisors's BIIB Position: Q1 2016 in Review

Denver Investment Advisors sold out of Biogen (BIIB) in Q1 2016, closing a stake of 789 shares — an estimated $242K sold.

Denver Investment Advisors first reported a position in BIIB in Q2 2013 and held it in 11 quarters. The position peaked at $5.5M in Q4 2013. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Denver Investment Advisors reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • Denver Investment Advisors sold 789 Biogen shares in Q1 2016, an estimated $242K.
  • Denver Investment Advisors first reported a position in Biogen in Q2 2013 and held it in 11 quarters.
  • Denver Investment Advisors's Biogen position peaked at $5.5M in Q4 2013.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Denver Investment Advisors's 13F filing for Q1 2016, filed 12 May 2016.